8 genome equivalents (GE) of HGV. The infection was characterized by the late appearance (weeks 10 and 11 after inoculation [pi]) of viremia that persisted throughout the 120-week follow-up. Serum HGV titer increased steadily until it plateaued at 10 6 -10 7 GE/mL. However, despite this relatively high titer, neither of the chimpanzees developed hepatitis. The sequence of the viral genome, recovered from each chimpanzee at week 77 pi, differed from that of the inoculum by 5 nt (2 aa) and 27 nt (2 aa). Two more chimpanzees were inoculated with a first-passage plasma pool. The chimpanzee inoculated with Ç10 6.7 GE of HGV had viremia at week 1 pi. However, the viral titer increased with the same kinetics as observed in the first passage. The second chimpanzee inoculated with Ç10 4.7 GE of HGV had late appearance (week 7 pi) of viremia.
quantitative RT-PCR (see below) and was negative for hepatitis merase), primer annealing at 45ЊC for 2 min, and DNA amplification at 72ЊC for 3 min. Finally, 15 mL of the product from the C virus (HCV) RNA. The T55875 sample was negative for HGV anti-E2 antibodies and for antibodies to HCV, hepatitis B virus, first and second rounds of PCR was analyzed by electrophoresis through a 2% agarose gel containing ethidium bromide followed human T cell lymphotropic virus, and human immunodeficiency virus.
by UV transillumination. Specificity was confirmed by sequence analysis of selected DNA products (see below). Each set of experiExperimental animals. A total of 4 chimpanzees (Pan troglodytes) and 5 tamarins (Saguinus mystax) were used in this study.
ments included a positive control sample (10 mL of serum obtained at week 21 from chimpanzee 1517, estimated titer Å 10 3 GE/mL) The animals were maintained under conditions that met all requirements for their use in an approved facility. The animals had not and at least 3 negative control samples. Samples were scored as negative if two independent tests on 100 mL of serum were negabeen inoculated intravenously with any material from animals or humans prior to this study. Serum samples and liver biopsies were tive in the RT-nested PCR assay. The sensitivity of our RT-nested PCR assay was equivalent to taken before inoculations, weekly for the first part of the study, and less frequently thereafter.
or better than the sensitivity of the RT-PCR assay performed at Genelabs (see above), as measured by testing a dilution series of Liver function tests. Serum was tested for the levels of alanine aminotransferase, g-glutamyl transpeptidase, and isocitrate dehy-T55875. We found that a 10 08 dilution of RNA (10 01 dilution contains the RNA extracted from 100 mL of plasma) extracted drogenase. Fixed liver tissue was examined for necroinflammatory changes.
from T55875 was the highest dilution positive for HGV RNA in the RT-nested PCR assay. We have defined 1 GE as the number Detection of HGV RNA. The RT-PCR assays were performed independently at Genelabs (chimpanzees 1517 and 1539) and at of HGV genomes present in the highest dilution positive in RTnested PCR. Thus, the genome titer of T55875 was 10 8 GE/mL. the National Institutes of Health. At Genelabs, sera were tested by RT-PCR assay as previously described [1] . In short, total RNA The HGV GE titer was determined in positive chimpanzee sera by performing RT-nested PCR on 10-fold serial dilutions of extracted was extracted from 125 mL of serum using the Purescript RNA Isolation Reagent (Gentra Systems, Minneapolis) according to the RNA.
Testing for HGV anti-E2 antibodies. Plasma or serum samples manufacturer's instructions. The RNA pellet was resuspended in 25 mL of RNase-free water. Total RNA, equivalent to 50 mL of were tested for HGV anti-E2 antibodies in the commercial ELISA mPLATE anti-HGenv (Boehringer Mannheim, Mannheim, Gerserum, was reverse-transcribed and amplified in duplicate with the 470-20-1 HGV-specific primers. Specific amplified sequences many) currently used for research purposes only [8] . We also used an independent ELISA assay for anti-E2 antibodies based on a were detected using an automated analyzer (QPCR System 5000; Perkin-Elmer, Norwalk, CT). Signals were positive if they were at highly purified E2 protein expressed in baculovirus (Belyaev A, Houghton M, Chien D; personal communications). least three times the average background in the duplicate reactions. Furthermore, specificity was confirmed in selected samples by Analysis of HGV genomic sequences. Almost the complete genome of HGV T55875 in the human plasma inoculum and in solution hybridization with a 32 P-labeled oligonucleotide probe, followed by gel electrophoresis and autoradiography. The sensitivthe first-passage chimpanzee serum from week 77 pi was amplified by RT-PCR with various primers deduced from the genomic seity of the RT-PCR assay was previously found to be 10 HGV genome copies per reaction [1] .
quence of the prototype isolate of HGV (HGV-1 [1] ) and/or from HGV T55875. We used primarily the long RT-PCR protocol that At the National Institutes of Health, sera were tested for HGV RNA by an RT-nested PCR. Total RNA was extracted from 100 we described previously [13] . In this protocol, the RT reaction is performed with Superscript II reverse transcriptase (Life TechnolomL of serum using the TRIzol reagent (Life Technologies Gibco BRL, Gaithersburg, MD) according to the manufacturer's recomgies Gibco BRL) and PCR is performed with the Advantage KlenTaq Polymerase Mix (Clontech, Palo Alto, CA). Products were mendations. The RNA pellet was resuspended in 10 mM dithiothreitol containing 5% (vol/vol) of RNasin (20-40 U/mL) (Promega, either sequenced directly or reamplified using the same polymerase or AmpliTaq DNA polymerase. In addition, selected genome reMadison, WI) and stored at 080ЊC. Total RNA equivalent to 10 mL or 100 mL of serum was tested in RT-PCR by amplification gions were amplified in the RT-nested PCR assay with AmpliTaq DNA polymerase. The DNA products were purified by the Wizard of the 5 UTR of HGV, essentially as described previously [12] , with an external primer pair of 5-AAGGTGGTGGATGGGTGA-PCR Prep (Promega), and both strands of DNA were sequenced using primers specific for HGV-1 and/or HGV T55875 with the TGACAG-3 and 5-AGAGAGACATTGAAGGGCGACGTG-3 and an internal primer pair of 5-ACAGGGTTGGTAGGTCGT-ABI PRISM Dye Terminator Cycle Sequencing Ready Reaction Kit using Taq DNA polymerase (Perkin-Elmer) to obtain a consen-AAATCC-3 and 5-TGGACCGTACGTGGGCGTCGTTTG-3 [11] . The RT was performed at 42ЊC for 1 h in a 20-mL reaction sus sequence. Computer analyses of the genomic sequences, including multiple sequence alignments and phylogenetic analyses, volume using avian myeloblastosis virus reverse transcriptase (Promega) and the external antisense primer. The cDNA was amplified were performed using a computer software package (GeneWorks; Oxford Molecular Group, Campbell, CA) [14] . in a 100-mL reaction volume in the nested PCR with AmpliTaq DNA polymerase or AmpliTaq Gold DNA polymerase (PerkinCloning of HGV genomic sequences. Amplified products were purified with QIAquick PCR purification kit (Qiagen, Santa ClarElmer). After one round of PCR with the external primer pair, 10 mL of the resulting product was reamplified in a second round of ita, CA), digested with HindIII and XbaI (Promega), and cloned into the multiple cloning site of pGEM-9zf(0)(Promega) using T4 PCR with the internal primer pair. study (week 32 pi), were positive for HGV RNA. Although this second passage resulted in the very early appearance of viremia, the genome titer increased at a rate similar to that in Results the first passage (figure 2). Serum liver enzyme values were normal throughout follow-up. Failure to infect tamarins with HGV. We inoculated each of 5 tamarins (S. mystax) intravenously with 0.5 mL of plasma
We also inoculated chimpanzee 1494 with 100-fold less virus (50 mL of the CH1517 pool). This chimpanzee was negative T55875. With one exception (week 1 pi in 1 animal), we did not detect HGV RNA in any of the serum samples taken during for HGV RNA for the first 6 weeks but became viremic at week 7 pi with genome titers of £10 GE/mL through week follow-up of 24 weeks in 1 animal and 40 weeks in 4 animals. Serum liver enzyme values were normal throughout follow-up 16 pi, and the titer reached 10 3 GE/mL at the end of the study (week 24 pi). Thus, inoculation with a lower dose of HGV in 4 animals. In the 5th animal, serum liver enzyme values were normal at weeks 1 -16 pi but were elevated at weeks 17 -resulted in the delayed appearance of viremia. Genetic analysis of the human HGV inoculum. We deter-24 pi, when this animal was sacrificed because of a chronically enlarged liver and increasing ascites unrelated to the inoculamined the consensus sequence of nearly the complete genome (corresponding to nts 21-9371 of HGV-1 [1] ) of HGV strain tion. Consecutive liver biopsies from this animal and from the animal found positive for HGV at week 1 pi lacked histologic T55875 recovered from human plasma. Of the 2 prototype strains of this virus (HGV-1 [1] , GBV-C [3] ), HGV T55875 evidence of viral hepatitis. Preinoculation samples from all 5 tamarins were tested for GBV-A -like viruses [15] because was most closely related to HGV-1 (figure 3), with sequence identities of 92.0% at the nucleotide level, 98.4% at the amino they are indigenous to tamarins and are genetically most closely related to HGV. Only 1 tamarin was infected. Thus, the failed acid level, and no insertions or deletions. Like the genomes of other HGV isolates, the genome of HGV T55875 did not enattempt to infect tamarins with HGV was not caused by viral interference from GBV-A. These data indicated that tamarins code a recognizable nucleocapsid protein, since the first inframe methionine codons were only 45 and 14 aa upstream of were not susceptible to experimental infection with HGV.
Transmission of HGV to chimpanzees. Chimpanzees 1517 the predicted E1 protein. The latter methionine is the only potential translation-initiation codon that is conserved among and 1539 were each inoculated intravenously with 1 mL of plasma T55875 (Ç10 8 GE of HGV). Both chimpanzees were all known HGV isolates [16] and was considered here as the first amino acid of the polyprotein. infected with HGV ( figure 1 ). The preinoculation sample and samples taken at weeks 1 -10 or 11 pi were negative for HGV Genetic analysis of HGV isolates recovered from infected chimpanzees. The consensus sequence of the viral genome RNA. Thereafter, HGV RNA was detected in each sample tested from weeks 11 -120 pi (at the end of follow-up). In both of HGV isolates recovered from chimpanzees 1517 and 1539 (first passage) at week 77 pi (HGV-1517 and HGV-1539) difchimpanzees, the serum virus titers were initially very low, with estimated genome titers of £10 GE/mL for 7 -8 weeks fered from that of the inoculum by only 5 nt (2 aa) and 27 nt (2 aa), respectively (table 1). The genomic regions found to but increased steadily over time until plateauing at 10 6 -10 7 GE/mL by week 44. Both animals were negative for HGV have substitutions in either chimpanzee were reamplified in RT -nested PCR and sequenced from equivalent amounts of anti -E2 antibodies throughout the experiment. In spite of the relatively high HGV titers reached later in the infection, neither HGV RNA from the inoculum and both chimpanzees. This independent analysis confirmed the presence of all of these of the 2 chimpanzees developed hepatitis. With one exception, serum levels of liver enzymes were normal, and necroinflamsubstitutions. Of interest, no changes were observed in the predicted E2 region. The HGV-1517 had a single nucleotide matory changes were not observed in the liver biopsies taken throughout follow-up. In chimpanzee 1517, serum liver enchange in the 5 UTR, and HGV-1539 had a different single nucleotide change in the 5 UTR, as well as one in the 3 UTR. zymes were elevated at week 21 pi; however, this finding could probably be ascribed to an open liver biopsy performed at week
In HGV-1517, amino acid changes were found in the predicted E1 (aa 151) and NS3 (aa 1342) proteins and, in HGV-1539, 20 pi.
Second passage of HGV in chimpanzees. The inoculum changes were found in NS3 (aa 1342) and NS4 (aa 1600) proteins. Thus, a single shared amino acid change in the RNA (CH1517 pool) used in the second passage was prepared from pooled plasmapheresis units from chimpanzee 1517 at weeks helicase domain of NS3 was found in both chimpanzees. The NS3 helicase region containing this common substitu-76 and 77 pi. This plasma pool contained Ç10 6 GE/mL of HGV (by semiquantitative RT-PCR) and was negative for HGV tion in the chimpanzees (at nt position 4576) was amplified in RT -nested PCR. No evidence of a quasispecies was found E2 antibodies. Chimpanzee 1500, inoculated intravenously / 9d43$$ap35 02-24-98 21:30:07 jinfas UC: J Infect at this position by direct sequencing of the PCR products. these clones. Yet, this substitution was found in the chimpanzees as early as week 21 pi and in all of 15 independent Furthermore, analysis of 15 independent clones of the NS3 region of the inoculum demonstrated that the nucleotide clones of the NS3 region derived from each of the 2 chimpanzees at week 77 pi. change found in the chimpanzees was not found in any of 1 [1]). Isolates analyzed were HGV T55875 (human inoculum), HGV CH1517 (virus recovered from chimpanzee 1517 at week 77 pi), HGV CH1539 (virus recovered from chimpanzee 1539 at week 77 pi), HGV 1 (prototype [1] ), HGV R10291 [1] , and GB virus C (prototype [3] ).
/ 9d43$$ap35
02-24-98 21:30:07 jinfas UC: J Infect Partial sequence analysis of the genomic sequences recovgenetically stable in its new host and achieved chronicity without accumulating a large number of mutations. ered from the second passage chimpanzees (1494 and 1500)
In the best-case scenario, the course of experimental infecinoculated with a plasma pool from chimpanzee 1517 demontion in an animal model reflects the course of the infection in strated that these became infected with HGV 1517. It should humans. For instance, in transfusion-associated HCV infection be emphasized that the first-passage substitution at position of humans, viremia was always detected by weeks 1 -2 pi, and 4576 (aa 1342) was maintained also in these second-passage experimental HCV infections of chimpanzees typically also chimpanzees.
resulted in the appearance of viremia by weeks 1 -2 pi ( [17, 18] ; Bukh J, unpublished data). In posttransfusion cases, HGV RNA was invariably detected in serum within 2 weeks after Discussion the transfusion [1, 5] . In contrast, HGV RNA was not detected In the present study, we established the chimpanzee as a in serum of the 2 chimpanzees inoculated with human plasma relevant animal model for HGV infection. The infection of until ú10 weeks after the experimental transmission, even chimpanzees by HGV was characterized by a reproducible, though the sensitivity of the RT-PCR assay used in this study slowly increasing virus titer that plateaued at 10 6 -10 7 GE/mL was high (see Materials and Methods). The virus titer of HGV achieved in humans after primary infection is somewhat variin the absence of any apparent disease. The human virus was able [5] . In general, the genome titer was initially low but suggests that the time to viremia could be dose-dependent. Although anti -E2 antibodies were not detected in either the increased to 10 4 -10 5 GE/mL 4 -12 weeks after transfusion. In the experimentally infected chimpanzees, the virus titer reached human or the first-passage inoculum, it is possible that the infectious titer of the human inoculum was significantly lower 10 4 GE/mL Ç15 weeks after the virus was first detected in the serum. Thus, it seems that the virus titer increases more slowly than indicated by the PCR titer. Clearly, further studies are needed to determine whether HGV adapted to its new host or in chimpanzees than in humans. Yet the peak virus titer was similar in humans and chimpanzees, and the persistent viremia whether there was a temporal relationship between virus dose and appearance of viremia. observed in the chimpanzees was characteristic of HGV infection in humans. Overall, although the viremic patterns of HGV The genomes of HGV isolates from around the world have nucleotide sequence identities of ú85% [16] . By comparison, infection of humans and chimpanzees differ slightly, this animal model should be useful for the study of HGV.
the genomes of HCV isolates have nucleotide sequence identities as low as 65% [14] . These data suggest that HGV may Clearance of HGV infection has been observed in posttransfusion hepatitis cases [1, 5, 7] , although clearance of viremia mutate at a lower rate than HCV, which mutates at an estimated rate of 1 -2 1 10 03 base substitutions per site per year (remay not occur until ú1 year after the primary infection [4, 5] . Antibodies to E2 were first detected immediately before and viewed in [14] ). Assuming that the chimpanzees became infected with the dominant virus in the inoculum, 5 and 27 nucleafter clearance, suggesting that they may have been responsible for resolution of the infection. The 2 chimpanzees persistently otide mutations accumulated in the 2 chimpanzees over 77 months. This corresponds to mutation rates of 3.6 1 10 04 and infected with HGV remained negative for antibodies to E2 and had relatively high titers of HGV for ú70 weeks prior to the 1.9 1 10 03 base substitutions per site per year, respectively. Thus, in 1 case, the mutation rate was lower than that observed end of follow-up at 120 weeks pi. The pattern of viremia in chimpanzees suggested that a neutralizing immune response for HCV, whereas in the other case it was the same. Recently, the mutation rate of HGV was found to be 3.9 1 10 04 base was not mounted.
Although HGV and GBV-C were identified in humans with substitutions per site per year in a Japanese patient receiving maintenance hemodialysis [24] . hepatitis, it is not clear whether this virus actually causes liver disease or is hepatotropic [5, 6] . Therefore, it may be relevant Persistence of HGV and HCV might occur by different mechanisms. HCV has a hypervariable region in the E2 protein that the chimpanzees infected with HGV did not develop hepatitis. The other identified hepatitis viruses (A, B, C, D, and E) that may circumvent the immune system and permit viral persistence [25] . A hypervariable region has not been identified do cause hepatitis when transmitted to chimpanzees. Of note, the viruses most closely related to HGV, GBV-A and related for HGV [16] . In the present study, HGV infection persisted for 120 weeks although only 2 amino acid changes occurred viruses, were also not associated with hepatitis [15, 19] . These species-specific GBV-A -like viruses chronically infect tamain each animal in the predicted polyprotein, and in 1 case, the changes were not even in the putative envelope proteins. There rins [15, 20, 21] . However, in the present study we found that, in spite of the relatively close evolutionary relationship of HGV were no amino acid changes in the E2 protein in either animal. Therefore, the persistence of HGV, in contrast to HCV, may and the GBV-A -like viruses, tamarins were not susceptible to infection with HGV.
not depend on neutralization-escape mutations.
In conclusion, chimpanzees, but not tamarins, were susceptiIt is well known that adaptation of viruses can affect their capacity to replicate in cell cultures and/or in animal models.
ble to HGV infection, and the virus was genetically stable in this new host. Except for the late appearance of viremia in It is conceivable that the human agent, HGV, underwent such adaptation during its first passage in the chimpanzee. First most cases, the course of infection of HGV in this animal model mimicked that in humans. Experimental infection of passage of the human virus in the chimpanzee resulted in the very late appearance of viremia, whereas the second passage, chimpanzees may provide important information on viral replication and pathogenesis of HGV. initiated with a somewhat lower GE titer than that in the human plasma, resulted in viremia as early as week 1 pi. However, the virus titer increased with similar kinetics in both passages. The HGV genome recovered from the first passage in chimpan-
